Filing Details

Accession Number:
0001209191-18-058826
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-15 19:23:19
Reporting Period:
2018-11-15
Accepted Time:
2018-11-15 19:23:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1710340 Eton Pharmaceuticals Inc. ETON () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1669976 Sean Brynjelsen 21925 W Field Pkwy #235
Deer Park IL 60010
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-15 24,940 $0.00 24,940 No 4 C Indirect by LLC
Common Stock Acquisiton 2018-11-15 10,000 $6.00 1,010,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect by LLC
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2018-11-15 23,000 $0.00 24,940 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Footnotes
  1. Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. The shares have no expiration date.